Stockreport

Agios Pharmaceuticals Teases 2026 Catalysts as PYRUKYND Thalassemia Launch Gains Early Traction [Yahoo! Finance]

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview
PDF and Agios estimating an initial U.S. addressable launch segment of ~4,000 patients within a ~6,000 diagnosed adult population, while management projects a $1 billion glo [Read more]